SEC Form 4 · accession 0000899243-17-012544
PALVELLA THERAPEUTICS, INC. · PVLA
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Christopher P Kiritsy
Director
Period of report
Apr 21, 2017
Accepted (ET)
May 9, 2017 · 6:30 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001583648
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common Stock | Apr 21, 2017 | M | 5,000 | $1.59 | A | 5,000 | D |
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Stock Option (right to buy)F1 | $1.59 | Apr 21, 2017 | M | 5,000 | D | — | Sep 20, 2026 | Common Stock | 30,000 | 25,000 | D |
Explanation of responses
- F1The stock option vests in four equal quarterly installments on each of September 30, 2016, December 31, 2016, March 31, 2017 and June 30, 2017, subject to the Reporting Person's continued service as a director.